Can pressurized oxygen stop breast cancer lung spread?

NCT ID NCT07514728

ENROLLING_BY_INVITATION Disease control Sponsor: Jinan Central Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This small study is testing whether hyperbaric oxygen therapy (HBOT) can help control the growth of breast cancer that has spread to the lungs. Ten women with advanced breast cancer and lung metastases will receive standard cancer treatment plus HBOT sessions. The goal is to see if the added oxygen therapy can shrink or stabilize lung tumors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber)
What this could lead to: If it works, this could point toward a new way to help control breast cancer that has spread to the lungs.
What could go wrong: This is a very small, early proof-of-concept study with only 10 participants. It is not yet known if hyperbaric oxygen therapy will be effective or safe for this purpose.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER HYPERBARIC OXYGEN THERAPY LUNG METASTASIS

Contacts and locations

Locations

Jinan Central Hospital

Jinan, Shandong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.